Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.

Hepatology (Baltimore, Md.) - 1 Aug 1997

von Weizsäcker F, Wieland S, Köck J, Offensperger W B, Offensperger S, Moradpour D, Blum H E

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Therapy
Share to Hepatitis, Viral, Human
Share to Mutation
Share to Oligonucleotides, Antisense

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RNA, Catalytic

Share to Viral Interference

Source

Identifiers

PMID: 9252130
DOI: 10.1002/hep.510260237

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.PMID 9252130Read ↗

Ribozyme gene therapy: applications for molecular medicine.Semantic proximity Read ↗

Hairpin ribozyme gene therapy for AIDS.Semantic proximity Read ↗

Progress and Prospects of Anti-HBV Gene Therapy DevelopmentSemantic proximity Read ↗

Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA virusesSemantic proximity Read ↗

Small Hairpin RNAs Efficiently Inhibit Hepatitis C IRES–Mediated Gene Expression in Human Tissue Culture Cells and a Mouse ModelSemantic proximity Read ↗

Gene Therapy for Infectious DiseasesSemantic proximity Read ↗

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.Semantic proximity Read ↗

Blocking sense‐strand activity improves potency, safety and specificity of anti‐hepatitis B virus short hairpin RNASemantic proximity Read ↗

New gene therapy strategies for hepatic fibrosisSemantic proximity Read ↗

Molecular therapeutics of HBV.Semantic proximity Read ↗

Phosphorothioate Oligonucleotides: Effectiveness and ToxicitySemantic proximity Read ↗

Synthetic Hammerhead Ribozymes as Therapeutic Tools to Control Disease GenesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.